Derivados do eugenol e isoeugenol e suas potencialidades antifúngica e antibiofilme

Detalhes bibliográficos
Autor(a) principal: Jardim, Jeane Uilma Galindo
Data de Publicação: 2019
Tipo de documento: Tese
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações da UFPB
Texto Completo: https://repositorio.ufpb.br/jspui/handle/123456789/19744
Resumo: This work describes the synthesis, characterization and antifungal potential and antibiofilm of eighteen monoterpene derivatives, nine of which are derived from eugenol and nine from isoeugenol. The synthesis of these compounds, which yielded satisfactory yields (74 to 92%), occurred in two steps: nine acetamides were initially synthesized and then these were derivatized with eugenol and isoeugenol separately in an etherification reaction of type SN2. All compounds, acetamides and derivatives were characterized by IR spectroscopic techniques, 1 H and 13 C NMR and the antifungal potential of the derivatives against Candida albicans strains and antibiofilm activity against Escherichia coli and Staphilococcus aureus were evaluated. Among the eighteen derivatives investigated, antifungal studies indicated that isoeugenol (E) 2- (2-methoxy-4- (prop-1-en-1-yl) phenoxy) -N-phenylacetamide and (E) - N- (4chlorophenyl) -2- (2-methoxy-4- (prop-1-en-1-yl) phenoxy) acetamide and the eugenol derivative 2- (4-allyl-2-methoxyphenoxy) -N- (4-allyl-2-methoxyphenyl) -N- (4-chloro-3-nitrophenyl) acetamide showed a strong inhibitory activity of 85 % of strains of the genus Candida. Anti-adherent activity was observed in six of the ten isoeugenol derivatives against E. coli, and the adhesion of only 2.9% of the isoeugenol (E) -2- (2-methoxy-4- (prop-1- en-1-yl) phenoxy) -N-phenylacetamide. For S. aureus, derivatives of isoeugenol (E) -N- (4-ethylphenyl) -2- (2-methoxy-4- (prop-1-en-1-yl) phenoxy) acetamide and (E) -2- (2-methoxy-4- (prop-1-en-1-yl) phenoxy) -N- (p-tolyl) acetamide exhibited excellent non-stick activity of less than 10%, and eugenol derivatives showed non-stick activity between 3.72 and 90.43%. All eugenol derivatives showed less than 10% antibiofilm activity against E. coli. Antibacterial studies showed that the lowest MIC was observed in the compound (E) 2- (2-methoxy-4- (prop-1-en-1-yl) phenoxy) -N- (4-methoxyphenyl) acetamide E. coli (35 μg / mL) and 2- (4-allyl-2-methoxyphenoxy) -N- (4-chloro-3-nitrophenyl) acetamide (66.8 μg / mL) for S. aureus. Quantitative Structure-Activity Relationships (QSAR) studies indicated that the descriptors that contributed significantly and positively to the isoeugenol series are DIFF (diffusivity, control of chemical dispersion in water at 25 ° C) and CP (critical packaging parameter) , whereas for the eugenol series only the descriptor V (molecular volume) which influences increasing, that is, a larger volume in an aqueous solution and greater repulsion to water results in considerable antifungal activity.
id UFPB_7a3c2b7d8a58f68c3b08e2e70a2ab6a5
oai_identifier_str oai:repositorio.ufpb.br:123456789/19744
network_acronym_str UFPB
network_name_str Biblioteca Digital de Teses e Dissertações da UFPB
repository_id_str
spelling Derivados do eugenol e isoeugenol e suas potencialidades antifúngica e antibiofilmeDerivados do eugenolDerivados do isoeugenolAcetamidas substituídasCandida albicansStaphilococcus aureusEugenol derivativesIsoeugenol derivativesSubstituted acetamidesCNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIAThis work describes the synthesis, characterization and antifungal potential and antibiofilm of eighteen monoterpene derivatives, nine of which are derived from eugenol and nine from isoeugenol. The synthesis of these compounds, which yielded satisfactory yields (74 to 92%), occurred in two steps: nine acetamides were initially synthesized and then these were derivatized with eugenol and isoeugenol separately in an etherification reaction of type SN2. All compounds, acetamides and derivatives were characterized by IR spectroscopic techniques, 1 H and 13 C NMR and the antifungal potential of the derivatives against Candida albicans strains and antibiofilm activity against Escherichia coli and Staphilococcus aureus were evaluated. Among the eighteen derivatives investigated, antifungal studies indicated that isoeugenol (E) 2- (2-methoxy-4- (prop-1-en-1-yl) phenoxy) -N-phenylacetamide and (E) - N- (4chlorophenyl) -2- (2-methoxy-4- (prop-1-en-1-yl) phenoxy) acetamide and the eugenol derivative 2- (4-allyl-2-methoxyphenoxy) -N- (4-allyl-2-methoxyphenyl) -N- (4-chloro-3-nitrophenyl) acetamide showed a strong inhibitory activity of 85 % of strains of the genus Candida. Anti-adherent activity was observed in six of the ten isoeugenol derivatives against E. coli, and the adhesion of only 2.9% of the isoeugenol (E) -2- (2-methoxy-4- (prop-1- en-1-yl) phenoxy) -N-phenylacetamide. For S. aureus, derivatives of isoeugenol (E) -N- (4-ethylphenyl) -2- (2-methoxy-4- (prop-1-en-1-yl) phenoxy) acetamide and (E) -2- (2-methoxy-4- (prop-1-en-1-yl) phenoxy) -N- (p-tolyl) acetamide exhibited excellent non-stick activity of less than 10%, and eugenol derivatives showed non-stick activity between 3.72 and 90.43%. All eugenol derivatives showed less than 10% antibiofilm activity against E. coli. Antibacterial studies showed that the lowest MIC was observed in the compound (E) 2- (2-methoxy-4- (prop-1-en-1-yl) phenoxy) -N- (4-methoxyphenyl) acetamide E. coli (35 μg / mL) and 2- (4-allyl-2-methoxyphenoxy) -N- (4-chloro-3-nitrophenyl) acetamide (66.8 μg / mL) for S. aureus. Quantitative Structure-Activity Relationships (QSAR) studies indicated that the descriptors that contributed significantly and positively to the isoeugenol series are DIFF (diffusivity, control of chemical dispersion in water at 25 ° C) and CP (critical packaging parameter) , whereas for the eugenol series only the descriptor V (molecular volume) which influences increasing, that is, a larger volume in an aqueous solution and greater repulsion to water results in considerable antifungal activity.NenhumaNeste trabalho descreve-se a síntese, caracterização e potencial antifúngico e antibiofilme de dezoito derivados de monoterpenos, sendo nove derivados do eugenol e outros nove do isoeugenol. A síntese desses compostos, que apresentou rendimentos satisfatórios (74 a 92 %), ocorreu em duas etapas: inicialmente foram sintetizadas nove acetamidas e em seguida estas foram derivatizadas com o eugenol e o isoeugenol, separadamente, em uma reação de eterificação do tipo SN2. Todos os compostos, acetamidas e derivados, foram caracterizados por técnicas espectroscópicas de IV, RMN de 1H e 13C e avaliou-se o potencial antifúngico dos derivados contra cepas de Candida albicans e a atividade antibiofilme contra Escherichia coli e Staphilococcus aureus. Dentre os dezoito derivados investigados, os estudos antifúngicos indicaram que os derivados do isoeugenol (E)-2-(2-metóxi-4(prop-1-en-1-il)fenóxi)-N-fenilacetamida e (E)-N-(4-clorofenil)-2-(2-metóxi-4-(prop1-en-1-il)fenóxi)acetamida e o derivado do eugenol 2-(4-alil-2-metóxifenóxi)-N-(4metóxifenil)acetamida inibiram moderadamente o crescimento das espécies de Candida e o derivado do eugenol 2-(4-alil-2-metóxifenóxi)-N-(4-cloro-3nitrofenil)acetamida apresentou uma forte atividade inibitória de 85 % das cepas do gênero Candida. A atividade antiaderente foi observada em seis dos dez derivados do isoeugenol frente a E. coli, sendo evidenciado a aderência de apenas 2,9% do derivado do isoeugenol (E)-2-(2-metóxi-4-(prop-1-en-1-il)fenóxi)-N-fenilacetamida. Em relação a S. aureus, os derivados do isoeugenol (E)-N-(4-etilfenil)-2-(2-metóxi-4(prop-1-en-1-il)fenóxi)acetamida e (E)-2-(2-metóxi-4-(prop-1-en-1-il)fenóxi)-N-(ptolil)acetamida apresentaram atividade antiaderente inferior a 10%, e os derivados do eugenol apresentaram atividade antiaderente entre 3,72 e 90,43%. Todos os derivados do eugenol apresentaram atividade antibiofilme inferior a 10% contra E. coli. Os estudos antibacterianos mostraram que a mais baixa CIM foi observada no composto (E)-2-(2-metóxi-4-(prop-1-en-1-il)fenóxi)-N-(4-metóxifenil)acetamida frente a E. coli (35 μg/mL) e por 2-(4-alil-2-metóxifenóxi)-N-(4-cloro-3-nitrofenil)acetamida (66,8 μg/mL) para S. aureus. Os estudos de relações quantitativas estrutura-atividade (QSAR) indicaram que os descritores que contribuíram significativa e positivamente para a série do isoeugenol são os DIFF (difusividade, controle da dispersão química em água a 25°C) e CP (Parâmetro de embalagem crítica), enquanto, para a série do eugenol, apenas o descritor V (volume molecular) o qual influencia de forma crescente, ou seja, um maior volume em uma solução aquosa e maior repulsão à agua resulta em atividade antifúngica considerável.Universidade Federal da ParaíbaBrasilFarmacologiaPrograma de Pós-Graduação em Produtos Naturais e Sintéticos BioativosUFPBBarbosa Filho, José Mariahttp://lattes.cnpq.br/8892459126928726Athayde Filho, Petrônio FilgueirasJardim, Jeane Uilma Galindo2021-03-17T14:51:55Z2019-09-302021-03-17T14:51:55Z2019-08-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesishttps://repositorio.ufpb.br/jspui/handle/123456789/19744porhttp://creativecommons.org/licenses/by-nd/3.0/br/info:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da UFPBinstname:Universidade Federal da Paraíba (UFPB)instacron:UFPB2021-06-29T13:30:50Zoai:repositorio.ufpb.br:123456789/19744Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufpb.br/PUBhttp://tede.biblioteca.ufpb.br:8080/oai/requestdiretoria@ufpb.br|| diretoria@ufpb.bropendoar:2021-06-29T13:30:50Biblioteca Digital de Teses e Dissertações da UFPB - Universidade Federal da Paraíba (UFPB)false
dc.title.none.fl_str_mv Derivados do eugenol e isoeugenol e suas potencialidades antifúngica e antibiofilme
title Derivados do eugenol e isoeugenol e suas potencialidades antifúngica e antibiofilme
spellingShingle Derivados do eugenol e isoeugenol e suas potencialidades antifúngica e antibiofilme
Jardim, Jeane Uilma Galindo
Derivados do eugenol
Derivados do isoeugenol
Acetamidas substituídas
Candida albicans
Staphilococcus aureus
Eugenol derivatives
Isoeugenol derivatives
Substituted acetamides
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
title_short Derivados do eugenol e isoeugenol e suas potencialidades antifúngica e antibiofilme
title_full Derivados do eugenol e isoeugenol e suas potencialidades antifúngica e antibiofilme
title_fullStr Derivados do eugenol e isoeugenol e suas potencialidades antifúngica e antibiofilme
title_full_unstemmed Derivados do eugenol e isoeugenol e suas potencialidades antifúngica e antibiofilme
title_sort Derivados do eugenol e isoeugenol e suas potencialidades antifúngica e antibiofilme
author Jardim, Jeane Uilma Galindo
author_facet Jardim, Jeane Uilma Galindo
author_role author
dc.contributor.none.fl_str_mv Barbosa Filho, José Maria
http://lattes.cnpq.br/8892459126928726
Athayde Filho, Petrônio Filgueiras
dc.contributor.author.fl_str_mv Jardim, Jeane Uilma Galindo
dc.subject.por.fl_str_mv Derivados do eugenol
Derivados do isoeugenol
Acetamidas substituídas
Candida albicans
Staphilococcus aureus
Eugenol derivatives
Isoeugenol derivatives
Substituted acetamides
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
topic Derivados do eugenol
Derivados do isoeugenol
Acetamidas substituídas
Candida albicans
Staphilococcus aureus
Eugenol derivatives
Isoeugenol derivatives
Substituted acetamides
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
description This work describes the synthesis, characterization and antifungal potential and antibiofilm of eighteen monoterpene derivatives, nine of which are derived from eugenol and nine from isoeugenol. The synthesis of these compounds, which yielded satisfactory yields (74 to 92%), occurred in two steps: nine acetamides were initially synthesized and then these were derivatized with eugenol and isoeugenol separately in an etherification reaction of type SN2. All compounds, acetamides and derivatives were characterized by IR spectroscopic techniques, 1 H and 13 C NMR and the antifungal potential of the derivatives against Candida albicans strains and antibiofilm activity against Escherichia coli and Staphilococcus aureus were evaluated. Among the eighteen derivatives investigated, antifungal studies indicated that isoeugenol (E) 2- (2-methoxy-4- (prop-1-en-1-yl) phenoxy) -N-phenylacetamide and (E) - N- (4chlorophenyl) -2- (2-methoxy-4- (prop-1-en-1-yl) phenoxy) acetamide and the eugenol derivative 2- (4-allyl-2-methoxyphenoxy) -N- (4-allyl-2-methoxyphenyl) -N- (4-chloro-3-nitrophenyl) acetamide showed a strong inhibitory activity of 85 % of strains of the genus Candida. Anti-adherent activity was observed in six of the ten isoeugenol derivatives against E. coli, and the adhesion of only 2.9% of the isoeugenol (E) -2- (2-methoxy-4- (prop-1- en-1-yl) phenoxy) -N-phenylacetamide. For S. aureus, derivatives of isoeugenol (E) -N- (4-ethylphenyl) -2- (2-methoxy-4- (prop-1-en-1-yl) phenoxy) acetamide and (E) -2- (2-methoxy-4- (prop-1-en-1-yl) phenoxy) -N- (p-tolyl) acetamide exhibited excellent non-stick activity of less than 10%, and eugenol derivatives showed non-stick activity between 3.72 and 90.43%. All eugenol derivatives showed less than 10% antibiofilm activity against E. coli. Antibacterial studies showed that the lowest MIC was observed in the compound (E) 2- (2-methoxy-4- (prop-1-en-1-yl) phenoxy) -N- (4-methoxyphenyl) acetamide E. coli (35 μg / mL) and 2- (4-allyl-2-methoxyphenoxy) -N- (4-chloro-3-nitrophenyl) acetamide (66.8 μg / mL) for S. aureus. Quantitative Structure-Activity Relationships (QSAR) studies indicated that the descriptors that contributed significantly and positively to the isoeugenol series are DIFF (diffusivity, control of chemical dispersion in water at 25 ° C) and CP (critical packaging parameter) , whereas for the eugenol series only the descriptor V (molecular volume) which influences increasing, that is, a larger volume in an aqueous solution and greater repulsion to water results in considerable antifungal activity.
publishDate 2019
dc.date.none.fl_str_mv 2019-09-30
2019-08-30
2021-03-17T14:51:55Z
2021-03-17T14:51:55Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://repositorio.ufpb.br/jspui/handle/123456789/19744
url https://repositorio.ufpb.br/jspui/handle/123456789/19744
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv http://creativecommons.org/licenses/by-nd/3.0/br/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nd/3.0/br/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal da Paraíba
Brasil
Farmacologia
Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos
UFPB
publisher.none.fl_str_mv Universidade Federal da Paraíba
Brasil
Farmacologia
Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos
UFPB
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da UFPB
instname:Universidade Federal da Paraíba (UFPB)
instacron:UFPB
instname_str Universidade Federal da Paraíba (UFPB)
instacron_str UFPB
institution UFPB
reponame_str Biblioteca Digital de Teses e Dissertações da UFPB
collection Biblioteca Digital de Teses e Dissertações da UFPB
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da UFPB - Universidade Federal da Paraíba (UFPB)
repository.mail.fl_str_mv diretoria@ufpb.br|| diretoria@ufpb.br
_version_ 1801842971331526656